Potassium p-Aminobenzoate

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Drug Interactions
  • Dosage
  • Special Considerations

Brand Names


Austria: Potaba; Germany: Potaba; Greece: Potaba; Ireland: Potaba; UK: Potaba.

North America

USA: Potaba.

Drug combinations


Potassium p-Aminobenzoate: C~7~H~7~KNO~2~. Mw: 176.23. 4-Aminobenzoate potassium salt. CAS-138-84-1.

Pharmacologic Category

Vitamins; Vitamin B Complex. (ATC-Code: D02BA01).

Mechanism of action

Member of vitamin B complex family. May have antifibrotic effect due to increased oxygen uptake at tissue level.

Therapeutic use

Treatment of scleroderma, dermatomyositis, morphea, linear scleroderma, pemphigus, Peyronie’s disease.

Pregnancy and lactiation implications

Safety for use in pregnancy not established. Not recommended in breast-feeding (excretion in breast milk unknown).

Unlabeled use


Hypersensitivity to potassium p-aminobenzoate or any component of the formulation. Concurrent use of sulfonamides.

Warnings and precautions

Anorexia might occur. Nausea might occur. Use with caution in diabetes mellitus or history of hypoglycemia, and in renal impairment.



Legal Notice
Privacy Policy
Cookie Policy


Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart